CHD RISK Glycemia 75g OGTT Time Metabolic Syndrome

Slides:

Advertisements

Similar presentations

The ABCs of CAD Prevention Gina Ryan, PharmD, BCPS, CDE Clinical Associate Professor Mercer University College of Pharmacy and Health Sciences.

Advertisements

1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.

Metabolic Syndrome Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference Circulation. 2004;109:

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Diabetes Mellitus Type 2

Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?

COMMON LIFESTYLE DISEASES

LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)

Cardiovascular Disease in Women Module III: Risk Assessment Tool.

Screening for Diabetes in Pregnancy 1. Gestational Diabetes Mellitus Screening GDM, gestational diabetes mellitus. Handelsman YH, et al. Endocr Pract.

Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Implications for Preventive Cardiology Nathan D. Wong, PhD, FACC, FAHA Professor and Director.

Lifestyle Medicine 101 Presented by ACLM Professionals in Training Executive Board 2014.

Obesity M.A.Kubtan MD - FRCS M.A.Kubtan1. 2  Pulmonary Disease  Fatty Liver Disease  Orthopedic Disorders  Gallbladder Disease  Psychological Impact.

METABOLIC Syndrome: a Global Perspective

Prevention of Type 2 Diabetes. Hyperglycemia in Type 2 Diabetes: Changing Treatment Paradigms.

Metabolic Syndrome Yusra Mir, MD Zunairah Syed, MD Harjagjit Maan, MD.

STUDY REGARDING THE LIFESTYLE AND EATING HABITS AS RISK FACTORS FOR HEART DISEASE, IN CORONARY PATIENTS FROM THE HEART DISEASE CLINIC II ADULTS UMF Tg-Mures.

Leveraging Weight Loss in the Treatment of Type 2 Diabetes Part 1 of 4.

Hyperglycemia and Acute Coronary Syndromes. Cardiovascular disease and diabetes Bell DSH. Diabetes Care. 2003;26: Centers for Disease Control.

Screening for Type 1 & Type 2 Diabetes Key Messages In the absence of evidence for interventions to prevent or delay type 1 diabetes, screening for type.

The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.

The Obesity/Diabetes Epidemic: Adiposopathy & Obesity- The New Disease! Dx & (Rx) of Insulin Resistance & early DM Part 3 Stan Schwartz MD, FACP, FACE.

Plasminogen-Activating Inhibitor-1 (PAI-1) High PAI-1 associated with: Obesity (especially visceral), possible fatty liver. 2,3,4 Inflammation and oxidative.

Cardiometabolic Syndrome Nabil Sulaiman HOD Family and Community Medicine, Sharjah University and University of Melbourne & Dr Dhafir A. Mahmood Consultant.

Metabolic syndrome from a gender and cardiovascular perspective Eva Swahn.

The FATZO mouse as a Translational Model for the Development of Drugs for Obesity, Metabolic Syndrome and Diabetes. PreClinOmics, Inc. 1.

Metabolic Syndrome By: Dr.AP.Ahmed el-Shaer Dr.Mohamed El-Zayat.

Insulin Resistance Progression to Diabetes. Hypertension: BP >140/90 Dyslipidemia: ◦TG >150 mg/dL (1.7 mmol.L) ◦HDL-C

Identify the risk factors, diagnosis and prevalence of diabetes in the United States. Describe the function of the pancreas, the intestines and liver.

Epidemiology and Diagnosis A Practical Guide to Therapy Monotherapy Combination Therapy Add ons.

 2010 Cengage-Wadsworth Preventing Cardiovascular Disease Chapter 11.

Metabolic Syndrome: Focused on AMPK as Molecular Target for Metabolic Syndrome Bayu Lestari.

Chapter 14 Patterns in Health and Disease: Epidemiology and Physiology EXERCISE PHYSIOLOGY Theory and Application to Fitness and Performance, 6th edition.

Metabolic Syndrome Dr. Hasan AYDIN. Metabolic Syndrome Clustering of cardiovascular risk factors Central obesity Diabetes Hypertension Dyslipidemia.

Insulin Resistance Progression to Diabetes Part 3.

Chapter Exercise and Diabetes Dixie L. Thompson C H A P T E R.

Coronary artery disease (CAD), also called coronary heart disease, is a condition in which plaque (plak) builds up inside the coronary arteries. These.

SARCOPENIC-OBESITY AND CARDIOVASCULAR DISEASE RISK IN THE ELDERLY The Journal of Nutrition, Health & Aging Pf. 진상욱 /R2. 최하나.

T HREE STRIKES IS ENOUGH Karalyn J Huxhagen B Pharm FPS AACPA Cardiovascular Health Sleep Apnoea Diabetes.

Risk of Progression to Type 2 Diabetes Based on Relationship Between Postload Plasma Glucose and Fasting Plasma Glucose Diabetes Division and the Clinical.

Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: The metabolic syndrome, diabetes, and subclinicalatherosclerosis.

Yusra Mir, MD Zunairah Syed, MD Harjagjit Maan, MD

Utilizing Anti-diabetic Agents to Manage Cardiovascular Disease in T2DM Patients James LaSalle, D.O., FAAFP.

Anesthes. 2008;108(3): doi: /ALN.0b013e Figure Legend:

Menzies Health Institute Queensland

Screening for Diabetes in Pregnancy

Chapter 7 Metabolic syndrome

ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH CRITERIA FOR THE CLINICAL DIAGNOSIS OF THE METABOLIC SYNDROME AS PROPOSED BY THE NCEP-ATP III Metabolic.

AIM-HIGH Niacin Plus Statin to Prevent Vascular Events

Deciphering Obesity Management Guidelines

Screening and Monitoring

המשותף לכל סוגי הסוכרת היפרגליקמיה כרונית.

Screening for Diabetes in Pregnancy

Obesity and Dyslipidemia: How Would You Treat?

In Metabolic Syndrome Hyperinsulinism Creates the Vicious Cycle: Increased MAP-kinase pathway Circulation. 2005;111: Metabolic Syndrome A Comprehensive.

Vascular biology of metabolic syndrome

Section VII: Summary New focus on treating hypertension beyond the numbers Content Points: In view of current clinical understanding of the link between.

Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53

Type 2 diabetes: Overlap of clinical conditions

Advanced Nutrition Diet and Cardiovascular Disease 1

Glucose Management and Statin Therapy

Is Growth Hormone Resistance/IGF-1 Reduction Good for You?

Time to abandon microalbuminuria?

Glucose Management and Statin Therapy

The proportion of patients confronted with a cardiovascular risk factor (CVRF) they were previously unaware of, referring to the instrument based tests.

High Risk of Heart Disease in South Asians

Insulin secretion/insulin resistance (disposition) index (ΔINS/ΔGLU ÷ IR) in subjects with normal glucose tolerance (NGT), impaired glucose tolerance (IGT),

Multivariate-adjusted HRs (95% CI) for deaths from CV disease (CVD), coronary heart disease (CHD), stroke, and all-cause mortality according to fasting.

ATP III Guidelines Benefit Beyond LDL-Lowering:

Presentation transcript:

CHD RISK Glycemia 75g OGTT Time Metabolic Syndrome RESPECTIVE CONTRIBUTION OF TYPE 2 DIABETIC HYPERGLYCEMIA VERSUS THE CLUSTERING OF ABDOMINAL OBESITY-RELATED RISK FACTORS (METABOLIC SYNDROME) TO THE INCREASED CORONARY HEART DISEASE (CHD) RISK IN DIABETES IGT NGT Glycemia 75g OGTT Time CHD RISK Metabolic Syndrome Abdominal Obesity Insulin Resistance Atherogenic Dyslipidemia Impaired Fibrinolysis Pro-thrombotic State Patient with Abdominal Obesity and Type 2 Diabetes Inflammation Increased Blood Pressure